Fremanezumab trials for Migraine

All Fremanezumab trials · All Migraine trials

Phase breakdown

Recruiting trials studying Fremanezumab for Migraine

• CGRP Inhibition, Autonomic Function, and Migraine
  NCT04628429 · Phase: Not specified · Ages: 18 Years to 64 Years · Sex: All (male and female) · 3 locations
• Fremanezumab for the Prevention of Menstrually-related Migraine Attacks
  NCT06659120 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 1 location
• Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symptoms Treated With Fremanezumab: A Study to Evaluate Whether Fremanezumab Reduces the Impact on Caregivers and Increases Couple Reciprocity
  NCT07029126 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 10 locations

Common questions

How many trials study Fremanezumab for Migraine?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.